# Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants

> **NCT02632266** · PHASE4 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Complication of Prematurity

## Interventions

- **DIETARY_SUPPLEMENT:** Powder HMF
- **DIETARY_SUPPLEMENT:** Liquid HMF

## Key facts

- **NCT ID:** NCT02632266
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632266, "Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02632266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*